# A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations

> **NCT01410747** · — · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 1484 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT01410747
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04-10
- **Primary completion:** 2020-01-31
- **Final completion:** 2020-01-31
- **Target enrollment:** 1484 (ACTUAL)
- **Last updated:** 2024-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01410747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01410747, "A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT01410747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*